ストックスクリーナーアプリを入手
6.17
1.91%
-0.12
Sanuwave Health Inc (SNWV) 最新ニュース
SNWV|SNWV|Price:6.170|Chg%:+0.240 - TradingKey
Calendrier des PAPE pour: - Yahoo Finance France
What's going on with SANUWAVE Health stock on Friday? - MSN
Sanuwave Q2 revenue exceeds revised guidance on record consumable sales - scanx.trade
What's Going On With SANUWAVE Health Stock On Friday? - Benzinga
SANUWAVE Health (SNWV) Stock Forum and Discussion - Moomoo
Sanuwave sees Q2 revenue up to $9.8M - MSN
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance - Ortho Spine News
Sanuwave Health preliminary revenue increases up to 5% in Q2 2026 - Medical Buyer
Sanuwave Health (SNWV) Raises Q2 Revenue Expectations to $9.6M-$9.8M - GuruFocus
Sanuwave Health Reports Q2 2026 Revenue Above Guidance Amid Record Consumable Sales and Used System Market Growth - Minichart
Sanuwave Health (SNWV) Reports Second Quarter Revenue Expectatio - GuruFocus
Sanuwave Health, Inc. Revises Earnings Guidance for the Second Quarter Ended June 30, 2026 - marketscreener.com
Sanuwave posts Q2 revenue of $9.6M-$9.8M, beating guidance By Investing.com - Investing.com Nigeria
Sanuwave posts Q2 revenue of $9.6M-$9.8M, beating guidance - Investing.com
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6-$9.8 Million, Above High End of Revised Guidance - The Manila Times
Sanuwave Health Reports Preliminary Second Quarter 2026 Revenue Above Revised Guidance Range - Quiver Quantitative
Press Release: Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6--$9.8 Million, Above High End of Revised Guidance - Moomoo
A Look at SANUWAVE Health Inc (SNWV) After 3.4% Decline -- GF Va - GuruFocus
SANUWAVE Health (SNWV) director granted 5,524 fully vested stock options - Stock Titan
SANUWAVE Health (SNVW) director granted 5,524 $10 options - Stock Titan
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 2000 Dynamic Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 3000E Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell Small Cap Completeness Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 2500 Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 3000 Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell 3000 Growth Benchmark - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Sanuwave Health, Inc. Actuals & Estimates (NASDAQ:SNWV) - TradingView
SNWV Q1 2026 Earnings: Wider-Than-Expected Loss Dampens Investor SentimentAnalyst Drop Coverage - DonanımHaber
SNWV Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Stock Rises 4.51%EPS Growth Rate - dars.gov.et
SANUWAVE Health (SNWV) Faces Selling Pressure, Tests Key Support After 4.66% DeclineFactor Rotation - dars.gov.et
SNWV Q1 2026 Earnings: Larger-Than-Expected Loss as Revenue Remains UndisclosedProfit Margin Analysis - dars.gov.et
SNWV: UltraMIST leverages clinical evidence and a consumables model to drive growth amid industry shifts - TradingView
Sanuwave Health eyes revenue up to USD 9.5M in Q2 2026 - Medical Buyer
Sanuwave Health expects Q2 revenue of $8.5M-$9.5M - scanx.trade
Top Midday Decliners - Moomoo
Sanuwave cuts Q2 revenue guidance on weak equipment sales By Investing.com - Investing.com South Africa
Sanuwave Health, Inc. Updates Earnings guidance for the Second Quarter 2026 - marketscreener.com
Sanuwave Health Cuts Q2 Revenue Guidance Amid Market Pressures - TipRanks
Sanuwave cuts Q2 revenue guidance on weak equipment sales - Investing.com
Sanuwave Health Updates Second Quarter 2026 Guidance - The Manila Times
Sanuwave updates Q2 revenue guidance to $8.5–$9.5M, applicator demand strong despite Ultramist headwinds - TradingView
Press Release: Sanuwave Health Updates Second Quarter 2026 Guidance - Moomoo
Sanuwave Health shareholders elect directors and approve auditor at annual meeting - Investing.com
Sanuwave Health Stockholders Approve Directors and Governance Matters - TipRanks
SANUWAVE Health (SNWV) Retreats From Resistance, Testing Key Support LevelsLast Point Support - newsline.com
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: Deep EPS Miss Raises Concerns Despite Stock RallyRevenue Warning Signal - newsline.com
SANUWAVE Health Q1 2026 Earnings: EPS Misses Estimates; Stock Rises Despite Wider LossROE Trend Analysis - newsline.com
SNWV: Director elections, auditor ratification, and executive pay were voted on; results pending - TradingView
SANUWAVE Health Inc Annual Shareholders Meeting Transcript - GuruFocus
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: Wider-than-Expected Loss Amid Pre-Commercialization PhaseConsensus Miss Rate - newsline.com
SANUWAVE Health (SNWV) Edges Lower Amid Consolidation Near ResistanceRetail Sentiment - dars.gov.et
Sanuwave (SNWV) Q4 2025 Earnings Transcript - The Globe and Mail
SANUWAVE Reports Record Q4 Revenue and Surging System Sales - HarianBasis.co
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: EPS Falls Short of Estimates, Stock DeclinesEarnings Volatility Report - dars.gov.et
SANUWAVE Health (SNWV) Slips 1.14% as Stock Tests Support Near $15.65Cash Secured Put - newsline.com
1.04%
11.95%
大文字化:
|
ボリューム (24 時間):